An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.
NCT00081588
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
555
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infection
Interventions
DRUG:
TMC114
Sponsor
Tibotec Pharmaceuticals, Ireland